| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |